RusBankrot
We know everything about bankruptcy
24/11/2024
Sunday
THIS DAY IN HISTORY:
24 November 
1970 The United States and the USSR ratified the nuclear non-proliferation treaty.
1970 The Central Committee of CPSU restored the national autonomy of the Kalmyks, Karachais, Balkars, Chechens and Ingush.
1970 Charles Darwin published The Origin of Species - the first edition was sold out in a day.
24 November
1970 The United States and the USSR ratified the nuclear non-proliferation treaty.
1970 The Central Committee of CPSU restored the national autonomy of the Kalmyks, Karachais, Balkars, Chechens and Ingush.
1970 Charles Darwin published The Origin of Species - the first edition was sold out in a day.
Company producing bionic eyes goes bankrupt, leaving patients without technical support
US customers of SSMP (Second Sight Medical Products) are at risk of being left without medical care with bionic prostheses implanted instead of their eyes. 350 visually impaired and blind people from different countries have trusted a company that offered fantastic technologies for partial vision restoration.
The company worked in the medical market of high technologies for 20 years. During this time, bionic implants of the Argus I and II models were developed. Blind people got the opportunity to see objects, distinguish shapes - someone was able to navigate in space, visit the stores on their own, go skiing. However, back in 2019, the firm announced that it would be phasing out retinal surgery.
In 2020, the firm found itself in a difficult financial situation and suspended operations. Its founder Robert Greenberg left the company, and many employees were laid off. According to the sources, doctors and technicians still have kept instruments and consumables for operations, but they are afraid to use them under the threat of criminal punishment.
An example of bankruptcy like SSMP raises serious questions for society about the justification of the risks that customers are forced to bear. After all, those who entrusted their health to the organization were promised a gradual improvement in the software and equipment used to create ‘artificial vision’. However, the patients got neither a quantitative improvement in visual perception, nor a qualitative service of their devices (except for a 4-hour operation, patients had to wear special glasses).
The company worked in the medical market of high technologies for 20 years. During this time, bionic implants of the Argus I and II models were developed. Blind people got the opportunity to see objects, distinguish shapes - someone was able to navigate in space, visit the stores on their own, go skiing. However, back in 2019, the firm announced that it would be phasing out retinal surgery.
The cost of installing and maintaining an eye implant was about $150,000.
And although a significant part of the amount, as a rule, was covered by insurance payments, the company went bankrupt. It turned out that the economic calculations were incorrect, and the amount did not cover all the expenses.In 2020, the firm found itself in a difficult financial situation and suspended operations. Its founder Robert Greenberg left the company, and many employees were laid off. According to the sources, doctors and technicians still have kept instruments and consumables for operations, but they are afraid to use them under the threat of criminal punishment.
Recently it became known that the company will become part of the Nano Precision Medical concern and will engage in completely different activities.
The head of the concern, Adam Mendelsohn, has already promised to resolve the issue. At the same time, the head of the company failed to explain to the media what kind of obligations the company had to patients with implanted bionic eyes.An example of bankruptcy like SSMP raises serious questions for society about the justification of the risks that customers are forced to bear. After all, those who entrusted their health to the organization were promised a gradual improvement in the software and equipment used to create ‘artificial vision’. However, the patients got neither a quantitative improvement in visual perception, nor a qualitative service of their devices (except for a 4-hour operation, patients had to wear special glasses).
21.02.2022
